Isolating cells expressing secreted proteins

Details for Australian Patent Application No. 2002245272 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Chen, Gang; Stahl, Neil; Fandl, James, P.; Yancopoulos, George, D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002245272

PCT Pub. Number WO2002/057423

Priority 60/261,999 16.01.01 US

Filing date 16 January 2002

Wipo publication date 30 July 2002

Acceptance publication date 29 June 2006

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002245272

29 June 2006 Application Accepted

  Published as AU-B-2002245272

26 October 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245273-A CMP POLISHING PAD INCLUDING A SOLID CATALYST

2002245271-Thiol-based NAALADase inhibitors